The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 1×
“Angiogenesis, which plays a critical role in tumor growth and metastasis [9], is driven by vascular endothelial growth factor (VEGF).”
BackgroundNile red: a selective fluorescent stain for intracellular lipid droplets.
Greenspan, P., Mayer, E. P., & Fowler, S. D. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.3.965 · Cited by 2,543
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275
Targeted drug delivery to tumors: Myths, reality and possibility
Bae, Y. H., & Park, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.001 · Cited by 1,935
Role of integrins in cell invasion and migration
Hood, J. D., & Cheresh, D. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc727 · Cited by 1,777
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Mechanism of DNA Release from Cationic Liposome/DNA Complexes Used in Cell Transfection,
Xu, Y., & Szoka, F. C. (1996) · Biochemistry · doi:10.1021/bi9602019 · Cited by 1,134
Ashley, C. E., Carnes, E. C., Phillips, G. K., Padilla, D., Durfee, P. N., Brown, P. A., Hanna, T. N., Liu, J., Phillips, B., Carter, M. B., et al. (2011) · Nature Materials · doi:10.1038/nmat2992 · Cited by 1,024
RNAi therapeutics: Principles, prospects and challenges
Aagaard, L., & Rossi, J. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.005 · Cited by 895
C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
Teesalu, T., Sugahara, K. N., Kotamraju, V. R., & Ruoslahti, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908201106 · Cited by 812 · cited 1×
“TLyP-1, a new tumor homing peptide containing the sequence motif (R/K)XX(R/K), has also been demonstrated to be able to mediate tissue penetration through neuropilin-1 dependent C-end Rule internalization [21], and the Cend Rule peptides can facilitate tissue penetration to overcome the problem caused by dysfunctional…”
BackgroundTargeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma
Huse, J. T., & Holland, E. C. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2818 · Cited by 763
Chen, A. M., Zhang, M., Wei, D., Stueber, D., Taratula, O., Minko, T., & He, H. (2009) · Small · doi:10.1002/smll.200900621 · Cited by 671
Bell, R. D., Sagare, A. P., Friedman, A. E., Bedi, G. S., Holtzman, D. M., Deane, R., & Zlokovic, B. V. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600419 · Cited by 670 · cited 3×
“As we know, the low-density lipoprotein receptor-related protein (LRP) receptor, overexpressed in both the bloodebrain barrier (BBB) [16] and human glioblastoma cells [17] [18], is a potential targeted moiety for glioma therapy.”
BackgroundGreco, F., & Vicent, M. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.05.006 · Cited by 652
Demeule, M., Currie, J., Bertrand, Y., Ché, C., Nguyen, T., Régina, A., Gabathuler, R., Castaigne, J., & Béliveau, R. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05492.x · Cited by 557 · cited 1×
“Angiopep-2, which is derived from the Kunitz domain, has been reported as a ligand that target to the LRP receptor and exhibits a higher brain penetration capability than other proteins, such as transferrin and lactoferrin [19,20].”
BackgroundIdentification and Design of Peptides as a New Drug Delivery System for the Brain
Demeule, M., Régina, A., Ché, C., Poirier, J., Nguyen, T., Gabathuler, R., Castaigne, J.-P., & Béliveau, R. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.131318 · Cited by 462
Robbins, M., Judge, A., & MacLachlan, I. (2009) · Oligonucleotides · doi:10.1089/oli.2009.0180 · Cited by 449
Xiong, X.-B., & Lavasanifar, A. (2011) · ACS Nano · doi:10.1021/nn2013707 · Cited by 411
Sun, T.-M., Du, J.-Z., Yao, Y.-D., Mao, C.-Q., Dou, S., Huang, S.-Y., Zhang, P.-Z., Leong, K. W., Song, E.-W., & Wang, J. (2011) · ACS Nano · doi:10.1021/nn103349h · Cited by 406
The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review
Wang, L. G., Liu, X. M., Kreis, W., & Budman, D. R. (1999) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050989 · Cited by 373
A review of nanocarriers for the delivery of small interfering RNA
Kesharwani, P., Gajbhiye, V., & Jain, N. K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.06.068 · Cited by 368
Mechanisms and kinetics of liposome–cell interactions
Düzgüneş, N., & Nir, S. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00037-x · Cited by 261
Gao, W., Xiang, B., Meng, T.-T., Liu, F., & Qi, X.-R. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.014 · Cited by 238
Self-citationIntracellular Drug Delivery by Poly(lactic-co-glycolic acid) Nanoparticles, Revisited
Xu, P., Gullotti, E., Tong, L., Highley, C. B., Errabelli, D. R., Hasan, T., Cheng, J.-X., Kohane, D. S., & Yeo, Y. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800137z · Cited by 234
Transtumoral targeting enabled by a novel neuropilin-binding peptide
Roth, L., Agemy, L., Kotamraju, V. R., Braun, G., Teesalu, T., Sugahara, K. N., Hamzah, J., & Ruoslahti, E. (2012) · Oncogene · doi:10.1038/onc.2011.537 · Cited by 231
Cao, N., Cheng, D., Zou, S., Ai, H., Gao, J., & Shuai, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.11.061 · Cited by 229
Maletínská, L., Blakely, E. A., Bjornstad, K. A., Deen, D. F., Knoff, L. J., & Forte, T. M. (2000) · PubMed · Cited by 211
Buyens, K., De Smedt, S. C., Braeckmans, K., Demeester, J., Peeters, L., van Grunsven, L. A., de Mollerat du Jeu, X., Sawant, R., Torchilin, V., Farkasova, K., et al. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.10.009 · Cited by 205
Hu, Q., Gu, G., Liu, Z., Jiang, M., Kang, T., Miao, D., Tu, Y., Pang, Z., Song, Q., Yao, L., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.048 · Cited by 194
Nanoparticles Targeted With NGR Motif Deliver c-myc siRNA and Doxorubicin for Anticancer Therapy
Chen, Y., Wu, J. J., & Huang, L. (2010) · Molecular Therapy · doi:10.1038/mt.2009.291 · Cited by 190
New advances that enable identification of glioblastoma recurrence
Yang, I., & Aghi, M. K. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.150 · Cited by 153
Price, M., Cornelius, R. M., & Brash, J. L. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00330-3 · Cited by 152
Berns, A. J. M. (2005) · Nature · doi:10.1038/436787a · Cited by 146
The antitumor effect of novel docetaxel-loaded thermosensitive micelles
Li, R., Yang, M., Li, R., Ding, Y., Qian, X., Yu, L., & Jiang, X. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.01.015 · Cited by 139
PSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancer
Xiang, B., Dong, D., Shi, N., Gao, W., Yang, Z., Cui, Y., De-ying, C., & Qi, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.055 · Cited by 139
Self-citationBastiat, G., Pritz, C. O., Roider, C., Fouchet, F., Lignières, E., Jesacher, A., Glueckert, R., Ritsch‐Marte, M., Schrott‐Fischer, A., Saulnier, P., et al. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.06.014 · Cited by 135
Surface‐Modified LPD Nanoparticles for Tumor Targeting
Li, S., & Huang, L. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1348.001 · Cited by 123
Yamamoto, M., Ikeda, K., Ohshima, K., Tsugu, H., Kimura, H. J., & Tomonaga, M. (1997) · PubMed · Cited by 102
In vitro and In vivo Evaluation of Docetaxel Loaded Biodegradable Polymersomes
Upadhyay, K. K., Bhatt, A. N., de Castro, E. D. M., Mishra, A. K., Chuttani, K., Dwarakanath, B. S. R., Schatz, C., Meins, J. L., Misra, A. R., & Lecommandoux, S. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.200900415 · Cited by 98
Frumovitz, M., & Sood, A. K. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.10.062 · Cited by 68
Tong, S.-W., Xiang, B., Dong, D., & Qi, X. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.06.014 · Cited by 61
Self-citationAnti-glioma effect and safety of docetaxel-loaded nanoemulsion
Gao, H., Pang, Z., Pan, S., Cao, S., Yang, Z. H., Chen, C., & Jiang, X. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-0214-8 · Cited by 61
Self-citationElucidating the Encapsulation of Short Interfering RNA in PEGylated Cationic Liposomes
Buyens, K., Demeester, J., Smedt, S. C. D., & Sanders, N. N. (2009) · Langmuir · doi:10.1021/la803973p · Cited by 57
Cited by
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
siRNA versus miRNA as therapeutics for gene silencing
Lam, J. K. W., Chow, M. Y. T., Zhang, Y., & Leung, S. W. S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.23 · Cited by 1,081
Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
Spicer, C. D., Jumeaux, C., Gupta, B., & Stevens, M. M. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00877e · Cited by 497
Progress and perspectives on targeting nanoparticles for brain drug delivery
Gao, H. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.05.013 · Cited by 495
Nakhaei, P., Margiana, R., Bokov, D. O., Abdelbasset, W. K., Jadidi Kouhbanani, M. A., Varma, R. S., Marofi, F., Jarahian, M., & Beheshtkhoo, N. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.705886 · Cited by 479
Retracted
Metadata
- Authors
- Yang, Z.-Z., Li, J.-Q., Wang, Z.-Z., Dong, D.-W., & Qi, X.-R.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 35
- Issue
- 19
- Pages
- 5226-5239
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2045651730
- Cited by
- 267
- References
- 43
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.